JBJulia Browne

Julia Browne

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Browne has a total of 146 co-authors. Here are the top co-authors by number of shared publications:

  • James L. Rudolph

    Center of Innovation in Long Term Services and Supports, VA Providence Healthcare System, Providence, RI, USA; Department of Health Services, Policy & Practice, Brown University, Providence, RI, USA

    5 shared publications
  • Wen-Chih Wu

    Center of Innovation on Transformative Health Systems Research to Improve Veteran Equity and Independence (THRIVE COIN), VA Providence Healthcare System , Providence, RI, 02908

    5 shared publications
  • Claudio Battaglini

    Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, Chapel Hill, USA

    4 shared publications
  • Kim T. Mueser

    Center for Psychiatric Rehabilitation and Departments of Occupational Therapy and Psychological and Brain Sciences, Boston University, Boston, MA, USA

    4 shared publications
  • Richard Sloane

    Geriatric Research, Education and Clinical Center, Durham VA Health Care System, Durham, NC, USA

    4 shared publications
  • Tonya Elliott

    Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA

    4 shared publications

Latest Publications

  • A Pilot Feasibility Study of a Virtual Lifestyle Intervention for Individuals with Schizophrenia

    by Julia Browne, Brittany M. Gouse, Janice Weinberg, Amelia Blanton, Gabrielle Simons, Olivia Thomas, Luisa Camacho, Lisa LeFeber, Nandini Agarwal, Abigail L. Donovan, et al.

    Individuals with schizophrenia experience early mortality from physical health conditions. Lifestyle interventions are effective; however, barriers interfere with in-person program participation. This two-period randomized cross-over pilot study evaluated the feasibility and acceptability of a virtual lifestyle intervention in n = 19 individuals with schizophrenia. Secondary analyses explored outcome changes between intervention and control groups. Results indicated modest retention (58%) and intervention engagement (67%) for Period 1 (weeks 1–11) with especially low rates in Period 2 (weeks 12–22; retention: 37%, intervention engagement: 50%). Of participants with satisfaction data (n = 6), nearly all participants reported that the intervention was helpful and easy to follow. Secondary outcome changes during Period 1 favored the intervention group on nutritional knowledge, physical activity, mental health, physical health, exercise motivation, self-esteem, and weight/body mass index (Cohen’s ds: 0.35–2.09). Due to attrition and sparsity of data, neither a cross-over design analysis nor examination of outcome changes during Period 2 was conducted. Although satisfaction results and outcome changes from Period 1 were encouraging, the low rates of retention and intervention engagement in Period 2 raise feasibility concerns. Intervention development research is needed to determine whether modifications to this virtual lifestyle intervention would enhance feasibility and acceptability for people with schizophrenia.

  • Suicidal Behavior Patterns and Correlates in High‐Risk Adults After Emergency Department Discharge: A One‐Year Prospective Study

    by Ana Rabasco, Julia Browne, Zachary Kunicki, Madeline B. Benz, Sarah A. Arias, Lauren M. Weinstock, Ivan Miller, Edwin Boudreaux, Carlos A. Camargo, Brandon A. Gaudiano

    Introduction: The time following emergency department (ED) discharge is a high‐risk period for suicidal behavior. This study examined correlates of suicidal behavior patterns over one‐year follow‐up among adults presenting to the ED with active suicidal thoughts and behaviors. Methods: Participants were n = 863 adults presenting to the ED with active suicidal thoughts and behaviors followed for one year post‐discharge. Participants were categorized into four suicidal behavior groups: none (no suicidal behavior at baseline or follow‐up), worsening (no suicidal behavior at baseline but at follow‐up), improving (suicidal behavior at baseline but not follow‐up), or persistent (suicidal behavior at both timepoints). We used binary logistic regression models to compare persistent versus improving and worsening versus none groups to examine factors that distinguished groups with the same baseline but different follow‐up suicidal behavior. Results: The most common suicidal behavior patterns were none (52.7%, n = 455) or improving (24.7%, n = 213). Risky alcohol use and previous psychiatric inpatient hospitalization distinguished participants in the worsening group from the none group. None of the factors distinguished the improving from the persistent group. Conclusions: Individuals with active suicidal ideation, alcohol use, and past psychiatric inpatient hospitalization may require additional support following ED discharge to prevent future suicide attempts.

  • Feasibility and Acceptability of a Single-session Self-regulation Intervention to Increase Physical Activity in Individuals with Serious Mental Illness: Results from a Pilot Open Trial

    by Julia Browne, Hannah E. Brown, Amelia Blanton, Julia London, Luisa Camacho, Jada Gibbs, Lisa LeFeber, Hannah Skiest, Paschal Sheeran, Corinne Cather

  • Weight Loss in Veterans with Schizophrenia and Multimorbidity Prescribed Semaglutide: Results From a National Retrospective Cohort Study

    by Julia Browne, Wen-Chih Wu, Lan Jiang, Thomas A Bayer, Zachary J Kunicki, Matthew Thompson, Melanie L Bozzay, Alyssa N De Vito, Matthew D Howe, Mriganka Singh, et al.

    Background and Hypothesis: People with schizophrenia are at heightened risk for physical multimorbidity and premature death. Semaglutide improves cardiometabolic outcomes, yet research is limited among individuals with schizophrenia. This study explored weight loss in Veterans with schizophrenia and physical multimorbidity (ie, heart failure and diabetes) prescribed semaglutide and compared weight changes to those in Veterans without schizophrenia. We hypothesized that those with schizophrenia would experience less weight loss compared to those without schizophrenia. Study Design: This retrospective cohort study examined national data from the Department of Veterans Affairs. The cohort included Veterans who filled a semaglutide prescription between 2018 and 2023 and had diagnoses of heart failure and diabetes. Body weight was examined one year prior to and one year following the first semaglutide prescription. Linear regression with inverse probability of treatment weighting (IPTW) was used to examine the relationship between schizophrenia status and one-year change in weight, accounting for hospital, demographic, clinical, and healthcare utilization factors. Study Results: The sample comprised n = 36 482 Veterans with physical multimorbidity (n = 559 with schizophrenia). The schizophrenia sample lost 3.1% of their baseline weight (raw weight loss = 8.7 pounds) and the sample without schizophrenia lost 4.7% of baseline weight (raw weight loss = 12.1 pounds). IPTW-adjusted regression analyses demonstrated significantly lower percent weight loss for those with schizophrenia compared to those without schizophrenia (Estimate = -0.85, 95% confidence intervals (CIs): -1.63, -0.07). Conclusions: Semaglutide appears to confer weight loss in Veterans with schizophrenia and multimorbidity, albeit at slightly lower amounts than those without schizophrenia.


  • Open Access

    A retrospective study of deceased veterans with serious mental illness and heart failure: Analysis of palliative care and mental health collaboration on hospice utilization

    by Jaclyn Boozalis, Jaclyn Perreault, Helen I. Turner, Wen-Chih Wu, Julia Browne, Lan Jiang, Mitchell Wice, James L. Rudolph, Jensy P. Stafford


  • Virtual Group-based Walking Intervention for Adults with Schizophrenia-Spectrum Disorders: Psychosocial Outcome Results from a Pilot Randomized Controlled Trial

    by Julia Browne, Zachary Kunicki, L. Fredrik Jarskog, Paschal Sheeran, Ana M. Abrantes, Tonya Elliott, Oscar Gonzalez, David L. Penn, Claudio Battaglini

    Physical activity improves mental health in individuals with schizophrenia. Yet, limited access, low motivation, and social isolation make participation in face-to-face programs challenging. This 16-week pilot randomized controlled trial examined differences in symptoms and loneliness between adults with schizophrenia that were randomized to a virtual group-based walking program (“Virtual PACE-Life”, n = 17) or Fitbit Alone (n = 20). The Positive and Negative Syndrome Scale and UCLA Loneliness scale were administered at baseline, 8 weeks, 16 weeks, and one-month follow-up. Standardized effects (SE) and confidence intervals from mixed effects models were used to evaluate group differences. Results demonstrated small-to-moderate effects (SE: 0.1–0.3) on total, negative, disorganization, excitement, and emotional distress symptoms favoring Virtual PACE-Life; however, negligible effects were observed for positive symptoms or loneliness. Despite the small sample size, these findings may suggest symptom but not loneliness benefits of a virtual group-based physical activity program for people with schizophrenia.

  • Open Access

    “One Size Doesn’t Fit All”: Design Considerations for an Exercise Program to Improve Physical Function in Older Veterans with Serious Mental Illness

    by Julia Browne, Whitney L. Mills, Courtney T. Lopez, Noah S. Philip, Katherine S. Hall, Alexander S. Young, Kate M. Guthrie, Wen-Chih Wu

    Older adults with serious mental illness (SMI) (i.e., schizophrenia, schizoaffective disorder, bipolar disorder) have compromised physical function that adversely affects their quality of life. Exercise is an effective intervention to improve function in older persons; however, older people with SMI experience barriers to exercise engagement. This study sought to obtain feedback on an exercise program in development for older people with SMI that comprised home-based exercise delivery, individualized exercise prescription, and motivational health coaching calls. Individual interviews and focus groups were conducted with older Veterans with SMI (n = 3) and clinical staff serving this population (directors: n = 3; clinicians: n = 15, k = 3) to elicit feedback on the perceived feasibility and acceptability of the preliminary program and recommendations for modifications to the program. Rapid analysis was used to summarize transcripts of audio-recorded interviews and focus groups. Results indicated a strong perceived feasibility and acceptability of the preliminary intervention because of how the individualized exercise prescription component (i.e., exercise plan) would be personalized to the Veteran’s preferences and abilities. Clinical staff participants expressed concerns about how the lack of real-time supervision would negatively affect exercise completion. Participants recommended tailoring the home-based exercise delivery and motivational health coaching calls components to each Veteran’s unique context.


  • A Novel Scale of Lifestyle Physical Activity: Measure Description and Intervention Responsiveness

    by Julia Browne, Tate F. Halverson, Cynthia L. Battle, Michael D. Stein, Alicia Bergeron, Ana M. Abrantes

    Lifestyle physical activity (LPA) interventions emphasize small bouts of movement that can be flexibly integrated into one’s everyday routine. Despite research illustrating benefits for LPA on health outcomes, few LPA interventions and measurement tools have been developed and tested. The purpose of this study was to present a novel LPA self-report scale, including its content, scoring, and internal consistency reliability, and summarize its intervention responsiveness. The LPA scale was administered in a pilot randomized controlled trial that tested a 12-week LPA + Fitbit intervention against a health education (HE) control (matched to LPA + Fitbit on contact time) in a sample of 50 women with depression in alcohol treatment. The LPA scale includes 22 items covering five domains relevant to LPA. Results demonstrated good internal consistency reliability for the total score (ω = 0.84) but poor-to-acceptable internal consistency reliability for the domain scores (ω range: 0.43-0.80). Participants randomized to the LPA + Fitbit intervention had significantly greater improvements in the LPA total score and two domain scores compared to HE participants. Overall, results demonstrate good internal consistency reliability and intervention responsiveness of the LPA scale total score. A larger, more comprehensive psychometric evaluation is needed for validation of this scale.


  • Open Access

    Engagement in a virtual group-based walking intervention for persons with schizophrenia: a qualitative study

    by Julia Browne, Claudio Battaglini, Aslihan Imamoglu, Bryan Stiles, L. Fredrik Jarskog, Paschal Sheeran, Ana M. Abrantes, Tonya Elliott, Oscar Gonzalez, David L. Penn

    Background: Exercise is beneficial for persons with schizophrenia; however, high dropout rates limit the impact of interventions. Virtual exercise programs have the potential to improve engagement; however, few intervention studies of virtual programs have been conducted in this population. Methods: This study examined qualitative data from 15 adults with schizophrenia who participated in a pilot randomized controlled trial of Virtual PACE-Life, a live, video-delivered group walking intervention guided by self-determination theory. Interviews elicited feedback on the intervention, barriers and facilitators to engagement, recommendations for intervention refinement, and preferences for exercise programming modality. Rapid qualitative analysis was used to explore similarities and differences between completers (i.e., those that attended ≥ 50% of virtual walking sessions; n = 9) and non-completers (i.e., those that attended < 50% of virtual walking sessions; n = 6). Results: Both groups viewed Virtual PACE-Life positively but found the virtual exercise sessions challenging and inadequate for facilitating social interaction. Work obligations impacted completers’ attendance whereas technological issues and forgetting impacted non-completers’ attendance at virtual walking sessions. Completers preferred virtual exercise programs and non-completers preferred in-person exercise programs. Conclusions: These findings suggest that future virtual group-based walking programs should prioritize enhancing the social aspect, offering scheduling choices, and regularly assessing the perceived difficulty of exercise sessions. These modifications not only have the potential to improve intervention engagement but they also may increase participant autonomy and relatedness, core components of self-determination theory.

  • Time to Dementia Diagnosis Among Veterans with Comorbid Insomnia and Depressive Episodes

    by Melanie L. Bozzay, Hannah E. Joyce, Lan Jiang, Alyssa N. De Vito, Sheina Emrani, Julia Browne, Thomas A. Bayer, McKenzie J. Quinn, Jennifer M. Primack, Catherine M. Kelso, et al.

    Background: Older adults with heart failure are at elevated risk of Alzheimer’s disease and related dementias (AD/ADRD). Research suggests that insomnia and depressive episodes contribute somewhat dissociable impacts on risk for AD/ADRD in this patient population, although the temporal ordering of effects is unknown. Objective: This study examined time to dementia diagnosis among patients with comorbid insomnia and/or depressive episodes in an epidemiological sample. Methods: Secondary data analyses were conducted using a cohort study of 203,819 Veterans with a primary admission diagnosis of heart failure in 129 VA Medical Centers. Results: Patients with diagnoses of both insomnia and depressive episodes had the shortest time to a dementia diagnosis at both 1-year (Hazard ratio = 1.43, 95% CI [1.36, 1.51]) and 3-year follow-up time points (Hazard ratio = 1.40, 95% CI [1.34, 1.47]) versus patients with one or neither comorbidity. Conclusions: Individuals with both comorbidities had the shortest time to dementia onset. Screening for these comorbidities may help to identify patients at elevated risk of dementia who could benefit from enhanced monitoring or early intervention strategies for more rapid detection and management of dementia symptoms.